ALMS
NASDAQ · Pharmaceuticals
Alumis Inc
$6.03
+0.18 (+3.08%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+306.5% upside
Low Target
$15.34
Average Target
$24.51
High Target
$36.47
Current Price
$6.03
Current
$6.03
$6.03
Target
$24.51
$24.51
$15.34
$24.51 avg
$36.47
Scenario Analysis
Bear Case
$15.34
154.4%
Low target
Base Case
$24.51
+306.5%
Avg target
Bull Case
$36.47
+504.8%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$31.35
-80.8% from high
52-Week Low
$4.40
+37.0% from low
50-Day SMA
$8.13
-25.8% vs SMA
200-Day SMA
$20.94
-71.2% vs SMA
RSI (14)
45.2
Neutral
Target vs 52W High
$24.51
-21.8% vs high
Next Earnings Report
Nov 12, 2026
4d
until earnings
EPS Est: $-0.76
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals